VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $136,972 | -13.1% | 5,090 | +4.5% | 0.10% | -13.2% |
Q2 2023 | $157,545 | 0.0% | 4,870 | 0.0% | 0.11% | 0.0% |
Q1 2023 | $157,545 | +12.9% | 4,870 | 0.0% | 0.11% | +8.6% |
Q4 2022 | $139,574 | +19.3% | 4,870 | 0.0% | 0.10% | +12.9% |
Q3 2022 | $117,000 | +34.5% | 4,870 | +53.6% | 0.09% | +45.3% |
Q2 2022 | $87,000 | -34.6% | 3,170 | -8.6% | 0.06% | -22.9% |
Q1 2022 | $133,000 | +19.8% | 3,470 | 0.0% | 0.08% | +23.9% |
Q4 2021 | $111,000 | +32.1% | 3,470 | +22.4% | 0.07% | +21.8% |
Q3 2021 | $84,000 | +90.9% | 2,835 | +117.2% | 0.06% | +83.3% |
Q2 2021 | $44,000 | +57.1% | 1,305 | +52.8% | 0.03% | +42.9% |
Q1 2021 | $28,000 | -9.7% | 854 | +0.6% | 0.02% | -19.2% |
Q4 2020 | $31,000 | +6.9% | 849 | +13.4% | 0.03% | -7.1% |
Q3 2020 | $29,000 | +7.4% | 749 | 0.0% | 0.03% | 0.0% |
Q2 2020 | $27,000 | +237.5% | 749 | +114.6% | 0.03% | +180.0% |
Q1 2020 | $8,000 | -11.1% | 349 | +16.7% | 0.01% | +11.1% |
Q4 2019 | $9,000 | – | 299 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |